Healthcare

The medical technology firm Carl Zeiss Meditec finds itself navigating a severe financial storm. A disastrous beginning to its 2025/26...

The rapid adoption of modern weight-loss drugs is triggering a fundamental realignment across the food industry. As pure-play snack manufacturers...

Pharmaceutical giant Pfizer is actively pursuing strategies to offset declining revenue from its COVID-19 products and establish new avenues for...

Stemtech Corporation has launched a dedicated digital sales channel, marking a significant shift in its distribution strategy. The new "Stemtech...

The focus for Remsleep and its investors is undergoing a significant shift. With the regulatory groundwork now firmly established for...

Shares of Electrocore are currently trading in a quiet phase, with broader macroeconomic concerns over inflation and global trade dominating...

For investors in Nexalin Technology, the focus has shifted from daily stock price movements to the company's underlying clinical progression....

The planned acquisition of RAPT Therapeutics by pharmaceutical giant GSK is entering its final stages. As the deal progresses toward...

The leader in robotic-assisted surgery is currently demonstrating robust performance, supported by impressive quarterly results and significant strategic advancements. Market...

The investment narrative surrounding Iovance Biotherapeutics is shifting. The company has reached a pivotal juncture, moving beyond pure research into...